A 38-year-old female presented with fever, shortness of breath and loss of appetite. Physical examination and electrocardiogram were unremarkable. Chest X-ray revealed pleural effusion and wide mediastinum.
Contrast-enhanced computed tomography (CT) showed a large heterogeneous anterior mediastinal mass invading the mediastinal structures and left anterior chest wall with encirclement and compression of the main and left pulmonary arteries. The mass invaded the pericardium and was inseparable from the ventricular walls (Fig. 1A, B, and C). CT guided biopsy was obtained and histopathology was consistent with a high-grade diffuse large B-cell lymphoma.
The patient underwent transthoracic echocardiogram (TTE) as part of routine work-up before chemotherapy. It uncovered normal left ventricular (LV) size with moderate systolic dysfunction and a large mass encircling the anterior and lateral LV walls causing akinesis (Fig. 1D, Supplementary movie 1). Cardiac magnetic resonance (CMR) confirmed the findings of TTE. The mass was hyperintense on T2-weighted and isointense on T1-weighted sequences with no evidence of perfusion. Additionally there was a non-ischemic sub-epicardial to mid wall late gadolinium enhancement involving the anterior wall with extension to a small portion of the anterior septum/anterolateral walls (Fig. 2, Supplementary movie 2). Those findings are in keeping with infiltration of the myocardial wall by the mediastinal lymphoma rather than an external compression.
She was treated with 3 cycles of combination chemotherapy (R-ESHAP; rituximab plus etoposide, cytarabine, cisplatinum, and methylprednisolone). Follow-up contrast-enhanced CT showed marginal improvement of the size and extent of the mediastinal mass. Unfortunately, the patient died after completion of chemotherapy and her mode of death was unwitnessed.
Diffuse large B-cell lymphoma is an uncommon category of primary mediastinal B-cell lymphoma that originates in the thymus. It is more prevalent in women and young adults. It usually presents with systemic symptoms, shortness of breath, chest discomfort, and palpable lymph nodes. It rarely manifests as an intracardiac mass and likely remains silent and often diagnosed on autopsy. With ventricular invasion, patients usually manifest with ventricular dysfunction which carries a dismal prognosis as noted in our patient.1)2)3)
The incorporation of multi-modality imaging is very important in the diagnosis and management of cardiac/extracardiac masses. Discrimination between cardiac infiltration by lymphoma and primary cardiac tumors is complicated. CMR and contrast enhanced CT are the most valuable tools in demarcating direct invasion by nearby mediastinal masses from primary cardiac tumors.4)5) In our case, CMR was very useful in depicting a direct infiltration of the myocardium by the mediastinal lymphoma rather than intracavitary involvement or merely an external compression by the mass.
References
2. O'Mahony D, Peikarz RL, Bandettini WP, Arai AE, Wilson WH, Bates SE. Cardiac involvement with lymphoma: a review of the literature. Clin Lymphoma Myeloma. 2008; 8:249–252.
3. Yang CC, Tsai HW, Lai ST, Wu HC, Lo CY, Chang Y. Mediastinal diffuse large B-cell lymphoma invading the left atrium mimicking coronary artery disease with a mural thrombus. J Chin Med Assoc. 2012; 75:606–609.
4. Goldman M, Matthews R, Meng H, Bilfinger T, Kort S. Evaluation of cardiac involvement with mediastinal lymphoma: the role of innovative integrated cardiovascular imaging. Echocardiography. 2012; 29:E189–E192.
5. Bley TA, Zeiser R, Ghanem NA, Hackanson B, Brink I, Langer M. High grade cardiac lymphoma vitality monitoring by gadolinium-enhanced magnetic resonance imaging (MRI). In Vivo. 2005; 19:689–693.